Login / Signup
Rosuvastatin and atorvastatin preserve renal function in HIV-1-infected patients with chronic kidney disease and hyperlipidaemia.
Leonardo Calza
Vincenzo Colangeli
Marco Borderi
Roberto Manfredi
Lorenzo Marconi
Isabella Bon
Maria Carla Re
Pierluigi Viale
Published in:
HIV clinical trials (2019)
In our study, rosuvastatin and atorvastatin showed a significant protective effect on the renal function compared to omega-3 fatty acids in HIV-1-infected patients with CKD and dyslipidaemia.
Keyphrases
</>
hiv infected
antiretroviral therapy
fatty acid
human immunodeficiency virus
chronic kidney disease